Tolvaptan, hyponatremia, and heart failure
International Journal of Nephrology and Renovascular Disease, 2011 Hammam D Zmily1, Suleiman Daifallah2, Jalal K Ghali31Wayne State University/Detroit Medical Center, Detroit, MI, USA; 2John D Dingell VA Medical Center, Detroit, MI, USA; 3Detroit Medical Center, Detroit, MI, USAAbstract: Tolvaptan is the first FDA ...
Zmily HD, Daifallah S, Ghali JK
doaj
Physiological responses of women to simulated weightlessness: A review of the first female bed-rest study [PDF]
Subjects were exposed to centrifugation, to lower body negative pressure (LBNP), and to exericse stress both before and after bed rest. Areas studied were centrifugation tolerance, fluid electrolyte changes and hematology, tolerance to LBNP, physical ...
Sandler, H., Winter, D. L.
core +1 more source
Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe hepatic encephalopathy [PDF]
, 2004 There is increasing evidence that terlipressin is useful in patients with cirrhosis and hepatorenal syndrome, but there are no data of its use in patients with acute liver failure (ALF) in whom hepatorenal syndrome is common.
Davies, N.A. +6 more
core
Total serum T3 and T4 in nontoxic goiter and autonomous adenoma [PDF]
, 1972 Borowzak, H. +5 more
core +1 more source
Tolvaptan and its potential in the treatment of hyponatremia
Therapeutics and Clinical Risk Management, 2008 Megan B Dixon, Y Howard LienDepartment of Medicine, University of Arizona, Arizona Kidney Disease and Hypertension Center, Tucson, Arizona, USAAbstract: Tolvaptan is a selective arginine vasopressin (AVP) V2 receptor blocker used to induce free water ...
Y Howard Lien, Megan B Dixon
doaj
The effect of changing gravity and weightlessness of vasopressin control systems [PDF]
An immunoassay to determine the effects of changing gravity and weightlessness on vasopressin control system is discussed. Seven extracts from persons known to have inappropriate ADH syndrome secondary to pulmonary oat cell cancer were examined.
Moran, W. H.
core +1 more source
Arginine Vasopressin (AVP) Deficiency: Diagnosis and Treatment - An Update. [PDF]
Indian J Endocrinol MetabChrist-Crain M.
europepmc +1 more source
Effects of arginine vasopressin deficiency on cardiac fibrosis in male Wistar rats. [PDF]
Physiol RepLimón-Mendoza A +7 more
europepmc +1 more source
Medication-Induced Severe Hyponatremia After Elective Surgery in a Patient With Known Arginine Vasopressin Deficiency. [PDF]
JCEM Case RepCaputo C, Tomar N, Beitner S.
europepmc +1 more source
Central Osmolality Sensing for Arginine Vasopressin Release Is Mediated by WNK1-OSR1/SPAK-Kv3.1 Cascade. [PDF]
FASEB JJin X +5 more
europepmc +1 more source